case 1: novel agents in superficial bladder cancer
Published 4 years ago • 127 plays • Length 8:35Download video MP4
Download video MP3
Similar videos
-
3:35
case 1: impact of the bcg shortage in bladder cancer
-
3:08
case 1: non-muscle invasive, bcg-refractory bladder cancer
-
4:24
case 4: multiple lines of therapy in recurrent bladder cancer
-
4:46
case 1: use of blue light cystoscopy in bladder cancer
-
7:41
bcg-refractory superficial bladder cancer
-
11:06
superficial bladder cancer
-
34:06
the optimization of intravesical chemotherapy for superficial bladder cancer
-
16:55
asco 2018: the latest in bladder cancer treatments
-
39:10
optimising the management of non-muscle invasive bladder cancer from diagnosis to cure
-
12:44
explaining integrative care in bladder cancer
-
8:24
case 2: combination therapy for cis-ineligible bladder cancer
-
36:31
novel anti-bladder cancer therapeutics
-
0:16
extreme cupping therapy! #shorts #cupping
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
45:08
r claudio aguilar - novel strategies for the targeted delivery of anti cancer drugs in bladder...
-
3:20
case 1: treatments for nmibc refractory to bcg
-
5:24
case 3: fgfr-targeted therapy adverse events in bladder cancer
-
6:38
case 2: exciting new treatment for cis-ineligible bladder cancer
-
8:29
case 4: considering special populations in bladder cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
13:38
multidisciplinary case 1 presentation: non muscle to muscle invasive progression
-
6:46
how is advanced bladder cancer treated?